Login
$EBS
$7.09 +$0.42 (6.3%) Close

$EBS DEF 14A SEC Filings

Filed On Filing
20 Mar 2026 Proxy statement: annual meeting on April 29, 2026

CEO pay $5.3M, down 9.2% · say-on-pay vote

21 Mar 2025 Proxy statement: annual meeting on April 30, 2025

CEO pay $5.9M · say-on-pay vote

11 Apr 2024 DEF 14A

CEO pay $5.1M, down 33%

14 Apr 2023 DEF 14A

CEO pay $7.6M, up 9.3%

15 Apr 2022 DEF 14A
09 Apr 2021 DEF 14A
09 Apr 2020 DEF 14A
12 Apr 2019 DEF 14A
13 Apr 2018 DEF 14A
13 Apr 2017 DEF 14A
08 Apr 2016 DEF 14A
10 Apr 2015 DEF 14A
07 Apr 2014 DEF 14A
08 Apr 2013 SCHEDULE 14A
06 Apr 2012 DEF 14A
07 Apr 2011 DEF 14A
09 Apr 2010 DEF 14A
03 Apr 2009 EMERGENT BIOSOLUTIONS INC.
15 Apr 2008 DEF 14A
30 Apr 2007 EMERGENT BIOSOLUTIONS INC.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support